LongueVue Capital (“LVC”) is pleased to announce that its portfolio company, Summit Clinical Research (“Summit” or the “Company”), in partnership with Pinnacle Clinical Research (“Pinnacle”), has successfully completed a strategic investment in Houston Research Institute (“HRI”) and strengthened its executive team. On February 28, 2025, Summit, an integrated research organization specializing in complex clinical trials with a network of over 120 sites, partnered with HRI, a Houston-based clinical research site focused on MASH/MASLD, cirrhosis, alcoholic liver disease, and obesity.
Read the full article: Summit Clinical Research Acquires Houston Research Institute and Deepens Leadership Team to Accelerate Growth and Enhance Scientific Expertise //
Source: https://www.prnewswire.com/news-releases/summit-clinical-research-acquires-houston-research-institute-and-deepens-leadership-team-to-accelerate-growth-and-enhance-scientific-expertise-302443665.html